Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term DNA and protein sulfur residues is a non-canonical and scientifically imprecise descriptor often used in toxicology to identify the nucleophilic sites within biological macromolecules that are susceptible to modification by electrophilic agents. In proteins, these residues primarily include the thiol groups of cysteine and the thioether groups of methionine, which are essential for structural integrity, enzymatic catalysis, and redox signaling (Ghezzi, 2005). However, standard human DNA does not naturally contain sulfur residues; instead, electrophilic agents typically react with nitrogenous bases, most notably the N7 position of guanine (StatPearls, 2023). The phrase is frequently encountered in the context of sulfur mustard toxicity, where the agent forms covalent adducts with both DNA and protein components, leading to systemic injury and cell death (PubChem, 2024). In clinical oncology, therapeutic agents such as nitrogen mustards interact with these nucleophilic sites to induce DNA cross-linking and apoptosis in malignant cells. Due to the ubiquitous nature of these chemical moieties, drugs targeting them often exhibit low specificity, resulting in significant safety concerns such as bone marrow suppression and the risk of secondary malignancies.
Covalent alkylation of nucleophilic sites leading to macromolecular cross-linking and functional impairment.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA and protein sulfur residues.